Ken Griffin Evogene Ltd. Transaction History

Citadel Advisors LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.61 - $0.82 $22,082 - $29,684	-36,201 Reduced 60.42%	23,710 $15,000
Q1 2024 May 15, 2024	BUY	$0.7 - $0.98 $2,233 - $3,127	3,191 Added 5.63%	59,911 $44,000
Q4 2023 Feb 14, 2024	BUY	$0.47 - $0.88 $13,739 - $25,724	29,232 Added 106.34%	56,720 $47,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.41 $8,926 - $21,701	15,391 Added 127.23%	27,488 $16,000
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.2 $25,104 - $53,796	-44,830 Reduced 78.75%	12,097 $12,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.86 $16,284 - $23,736	-27,601 Reduced 32.65%	56,927 $35,000
Q4 2022 Feb 14, 2023	SELL	$0.61 - $8.13 $7,426 - $98,982	-12,175 Reduced 12.59%	84,528 $59,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $8.65 $70,593 - $836,480	96,703 New	96,703 $80,000
Q1 2022 May 16, 2022	SELL	$1.09 - $1.83 $93,141 - $156,375	-85,451 Reduced 84.86%	15,244 $20,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $2.83 $41,291 - $71,689	25,332 Added 33.61%	100,695 $165,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $93,692 - $131,934	-38,242 Reduced 33.66%	75,363 $199,000
Q2 2021 Aug 16, 2021	SELL	$3.3 - $5.02 $129,198 - $196,538	-39,151 Reduced 25.63%	113,605 $388,000
Q1 2021 May 17, 2021	BUY	$4.29 - $9.94 $655,323 - $1.52 Million	152,756 New	152,756 $770,000
Q4 2019 Feb 14, 2020	SELL	$1.29 - $1.69 $24,993 - $32,743	-19,375 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.37 - $1.7 $7,570 - $9,394	5,526 Added 39.9%	19,375 $30,000
Q4 2018 Feb 14, 2019	BUY	$1.98 - $3.01 $27,421 - $41,685	13,849 New	13,849 $27,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.